EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations

Stella Diogo-Cavassana iD, Danillo Alencar-Coutinho iD, Rafaella Abreu-Oberhuber iD, Maria Eduarda Paramo-Neto iD, Jeanne Oiticica iD, Ricardo Ferreira Bento iD, Ana Carla Batissoco iD, Karina Lezirovitz iD

Clinical Genetics · 2026-08 · 110 (2) · 210-226

DOI: 10.1111/cge.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 03.06.2026. Verfasst von Stella Diogo-Cavassana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Otorrinolaringologia Genética Molecular, Celular e Translacional/LIM32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universi…. Hauptthemen laut MEDLINE: Hearing Loss, Genetic Predisposition to Disease. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, BGI GENOMICS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hearing loss (HL) is the most prevalent sensory disorder globally and a major public health challenge in Brazil, affecting over 1.5 million individuals. While over 150 HL‐associated genes have been identified, the genetic architecture in underrepresented populations remains poorly defined, often limiting diagnostic yield and precision medicine. We assessed the diagnostic performance of a comprehensive 218‐gene HL panel in 99 Brazilian probands (78 non‐syndromic; 21 syndromic) who had previously tested negative for GJB2/GJB6 (DFNB1) and MT‐RNR1 (m.1555A>G) and did not have ear malformations. Targeted next‐generation sequencing was followed by variant interpretation according to ACMG/AMP guidelines, segregation analysis, and longitudinal phenotypic re‐evaluation. Integration of Brazil‐specific allele‐frequency data was used to refine variant classification. A molecular diagnosis or a candidate variant was identified in 61 probands, yielding an overall diagnostic yield of 43%–62%, depending on classification stringency. We identified 19 novel variants across 15 genes, with MYO7A and MYO15A as the most frequently implicated. Notably, 10.4% of patients initially diagnosed with non‐syndromic HL carried pathogenic or likely pathogenic variants in syndromic genes ( PEX6, BSND, USH1C , and WFS1 ), necessitating clinical reclassification. Segregation analysis and phenotypic reassessment further enabled the reclassification of three variants of uncertain significance (VUS). In syndromic cases, a molecular diagnosis was established in 41% of cases, including Usher, Waardenburg, Branchio‐oto‐renal, and Bartter syndromes. This first large‐scale clinical genetic evaluation of hearing loss in Brazil demonstrates that comprehensive gene panels incorporating population‐specific data significantly improve diagnostic accuracy. Our findings broaden the mutational landscape of HL‐associated genes, reinforce the value of integrated genetic approaches for underrepresented populations, and underscore their direct impact on patient care and clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing LossGenetic Predisposition to DiseaseHumansBrazilFemaleMyosin VIIaMaleMutationConnexin 26PhenotypeMyosinsHigh-Throughput Nucleotide SequencingGene FrequencyGenetic Association StudiesChildConnexinsGenetic TestingChild, PreschoolAdolescent

Stichwörter der Autor:innen

Bartter syndromeHeimler syndromeNGSUsher syndromeWaardenburg syndromegenetic hearing loss

Substanzen

Myosin VIIaMYO7A protein, humanConnexin 26MyosinsMYO15A protein, humanGJB2 protein, humanConnexins

Autor:innen und Institutionen

  • Laboratório de Otorrinolaringologia Genética Molecular, Celular e Translacional/LIM32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Otorhinolaryngology Department, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

ORCID-Profile: Stella Diogo-Cavassana, Danillo Alencar-Coutinho, Rafaella Abreu-Oberhuber, Maria Eduarda Paramo-Neto, Jeanne Oiticica, Ricardo Ferreira Bento, Ana Carla Batissoco, Karina Lezirovitz

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • BGI GENOMICS

Zitieren

APA

Diogo-Cavassana, S., Alencar-Coutinho, D., Abreu-Oberhuber, R., Paramo-Neto, M. E., Oiticica, J., Bento, R. F., Batissoco, A. C., & Lezirovitz, K. (2026). Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations. Clinical Genetics, 110(2), 210-226. https://doi.org/10.1111/cge.70186

Vancouver

Diogo-Cavassana S, Alencar-Coutinho D, Abreu-Oberhuber R, Paramo-Neto ME, Oiticica J, Bento RF, et al. Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations. Clinical Genetics. 2026;110(2):210-226. doi:10.1111/cge.70186

BibTeX
@article{DiogoCavassana2026,
  author = {Diogo-Cavassana, Stella and Alencar-Coutinho, Danillo and Abreu-Oberhuber, Rafaella and Paramo-Neto, Maria Eduarda and Oiticica, Jeanne and Bento, Ricardo Ferreira and Batissoco, Ana Carla and Lezirovitz, Karina},
  title = {Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations},
  journal = {Clinical Genetics},
  year = {2026},
  volume = {110},
  number = {2},
  pages = {210--226},
  doi = {10.1111/cge.70186}
}
Kostenlos starten →